Cellular Repair & Recovery
KLOW
BPC-157 / TB-500 / GHK-Cu / KPV
KLOW — BPC-157 / TB-500 / GHK-Cu / KPV blend
Research context
KLOW combines four compounds with distinct reported mechanisms: BPC-157 in angiogenic signalling, TB-500 in actin sequestration, GHK-Cu in matrix and gene expression, and KPV in NF-κB pathway modulation. Each component is characterised independently in the published literature; the blend itself has not been separately characterised.
Common assays: Component identity by LC-MS · Purity per component · Collagen synthesis quantification
Specification
| Designation | BPC-157 / TB-500 / GHK-Cu / KPV |
|---|---|
| Full name | KLOW — BPC-157 / TB-500 / GHK-Cu / KPV blend |
| Components | BPC-157 · TB-500 · GHK-Cu · KPV |
| Formats | 10 mL Vial · 15 mL Advanced Liquid Peptide Spray |
| Solubility | Vial: bacteriostatic water, sterile water. Spray: supplied in metered spray format. |
| Storage | Vial, lyophilised: −20 °C, protected from light; reconstituted 2–8 °C. Spray: refrigerated 2–8 °C. |
| Current lot | BTGK1151VAS0626 → |
KLOW COA: certificates of analysis by lot
3 lots of KLOW have a published certificate of analysis from AxisPharm, LLC, an independent laboratory. Each certificate reports the laboratory's results for that lot.
| Lot | Format | Purity (HPLC-UV) | Reported |
|---|---|---|---|
| BTGK1151VAS0626 | 10 mg / 10 mg / 50 mg / 10 mg Vial | 99.2% | 2026-06-18 |
| KLOW202010020N0526 | 20 mg / 20 mg / 100 mg / 20 mg Spray | 99.3% | 2026-06-02 |
| BGTK1511VAS0246 | 10 mg / 10 mg / 50 mg / 10 mg Vial | >99.4% | 2026-04-30 |
Common questions
How is a four-component blend verified analytically?
Chromatographic separation must resolve all four peaks for individual quantification, with mass confirmation for each. The published lot record reports every component separately, with a measured content figure for each against its label claim.
Where can I see the KLOW certificate of analysis?
Every published KLOW lot has its own certificate page on this site, listed under "KLOW COA" above. There are 3 published lots; the most recent, lot BTGK1151VAS0626, was reported on 2026-06-18 at 99.2% purity by HPLC-UV. The certificates are issued by AxisPharm, LLC, an independent laboratory.
Components, blends and pathway
Related compounds
GHK-Cu
Copper tripeptide-1
A naturally occurring copper-binding tripeptide studied in extracellular matrix and gene expression research.
BPC-157
Body Protection Compound-157
A synthetic pentadecapeptide derived from a gastric juice sequence, studied in migration and angiogenesis models.
TB-500
Thymosin beta-4 fragment
A synthetic fragment corresponding to the actin-binding domain of thymosin beta-4.
KPV
Lys-Pro-Val tripeptide
The C-terminal tripeptide of α-melanocyte-stimulating hormone, studied in NF-κB signalling.